Page last updated: 2024-08-21

quinazolines and Inflammatory Response Syndrome, Systemic

quinazolines has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, J; Iekushi, K; Iwabayashi, M; Morishita, R; Rakugi, H; Sanada, F; Shimizu, K; Taniyama, Y1
Ozer, Z; Qazi, S; Tibbles, H; Uckun, FM; Vassilev, A1

Other Studies

2 other study(ies) available for quinazolines and Inflammatory Response Syndrome, Systemic

ArticleYear
Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradation.
    Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:11

    Topics: Animals; Aorta; Capillary Permeability; Cells, Cultured; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Hepatocyte Growth Factor; Humans; Inositol Polyphosphate 5-Phosphatases; Kidney; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phosphoric Monoester Hydrolases; Protein Kinase Inhibitors; Quinazolines; Reactive Oxygen Species; RNA Interference; Systemic Inflammatory Response Syndrome; Transfection; Vascular Cell Adhesion Molecule-1

2012
Anti-inflammatory activity profile of JANEX-1 in preclinical animal models.
    Bioorganic & medicinal chemistry, 2008, Feb-01, Volume: 16, Issue:3

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Hindlimb; Humans; Janus Kinase 3; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Quinazolines; Signal Transduction; Systemic Inflammatory Response Syndrome; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2008